Nobody does industry briefings like 3Sixty's Gerry Jeffcott (IQVIA industry briefing in Toronto)😎

🚨Registration now open for Module#2 of a 3-part Canadian Association of Medical Oncologists series on #Cancer #drugs #funding in 🇨🇦 🗓️Nov 15 #Virtual 7pmEST Register➡️camo-acom.ca/event-5472021 Sharlene Gill, MD, MPH, MBA, FASCO CAMOPREZ 3SixtyPublicAffairs

Don’t miss this opportunity to be part of an informative dialogue where our speakers, and panelists will address the #evolving #pharmaceutical #policy and how the market adapts to a reset. The conference will be moderated by Bill Dempster, CEO, 3SixtyPublicAffairs

The Neighbourhood Pharmacy Association of Canada Specialty Pharmacy Summit is almost here! Day 2 Session Spotlights: Join Bill Dempster for "Implementing the Drugs for Rare Diseases Strategy" and Andrew Bakhit for "Technology Trends for Delivering Specialty Services" #NPSummit

🚨Registration now open for Module#3 of a 3-part Canadian Association of Medical Oncologists series #Cancer #drugs #funding in 🇨🇦 🗓️Nov 30 #Virtual 7pm EST Register➡️camo-acom.ca/event-5498939 Sharlene Gill, MD, MPH, MBA, FASCO 3SixtyPublicAffairs Paul Wheatley-Price CAMOPREZ

Bill Dempster from @3sixtyPublicAffairs provides insights on the federal rare disease drug strategy & emerging provincial strategies: what they mean for pharmacies and how to shape implementation #NPSummit

3Sixty's Bill Dempster doing his thing at CORD's (CORD) Fall #RareDisease Conference! Inspiring community. Amazing discussions. 👏 #Canada4Rare

Fantastic afternoon of collaborative efforts! 🤝 Huge shoutout to the amazing facilitators, Bill Dempster 3SixtyPublicAffairs, for steering the ship. 🚀 Grateful for the teamwork at #Canada4Rare during #CORDFallConf in #Calgary! 🇨🇦

All smiles at CAHR: Canadian Assoc. for Healthcare Reimbursement National Day 😎

Happy holidays from the 3Sixty team! #XmasPartyShenanigans #NoFilter Bill Dempster

A huge thank you to all our sponsors for their continued support! 3SixtyPublicAffairs AstraZeneca Biogen Innovative Medicines Canada @Innomar_AB Abbott WestPAR CSL MORSE Consulting Inc Vertex Pharmaceuticals Roche Bausch Health Companies, Inc. Moderna GlobalPublicAffairs Novartis

👀Spotted: 3Sixty's Gerry Jeffcott at CAHR: Canadian Assoc. for Healthcare Reimbursement Western Day.

Thank you 👏Impacts on Rare Disease Drugs Panel Quebec Rules: Implications for Rare Sylvie Bouchard, INESSS at the Podium Bill Dempster moderating 3SixtyPublicAffairs, PMPRB Regulatory Changes Wayne Critchley , Global Public Affairs Emerging Therapies Bob McLay, @SobiNAmerica

Canadian Pathway to Rare Disease Drug Access: Sherry O’Quinn, MORSE Consulting Inc; Lindy Forte, EVERSANA ; Alexandra Chambers, Bayer AG ; Joan Paulin, @PHACanad Bonnie Kam, @JanssenCanada, Rute Fernandes, Takeda moderated by Bill 3SixtyPublicAffairs

Your favourite duo is back for some more “eye spy with my little eye” on the way to next week’s IQVIA’s Industry Briefings in Toronto (Apr 16) and Montreal (Apr 17)! See you there!

3Sixty is thrilled to announce two new additions to our growing team. Please join us in welcoming Chris Gray and Doug Nanton to the 3Sixty family 👏👏 linkedin.com/feed/update/ur…

3Sixty's Bill Dempster and Gerry Jeffcott are PharmaFocused at IQVIA's Industry Briefing in Montreal😎

Spotted 👀 3Sixty’s Fred Horne discusses patient-centric healthcare GI Society’s #InsideAffair

The federal health committee is wrapping up its review of Bill-C64, An act respecting pharmacare. Want to know what happens next? 3Sixty’s new infographic explains the entire process including next steps after the bill passes.

How Can We Better Protect Older Canadians – A Booster Shot for Canada’s Vaccine Policies Join Ronald Grossman Temerty Medicine; Laura Tamblyn Watts CanAge; Jennifer Chan @MerckCanada; Moderator Bill Dempster, 3SixtyPublicAffairs for a #LeadershipDiscusson on Feb 6. longwoods.com/events/leaders…